Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer-Reference-Cited by-同舟云学术

Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer

Published:2015-04-27 Issue:8 Volume:137 Page:2000-2006
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Kümler Iben¹,Balslev Eva²,Poulsen Tim S.²,Nielsen Signe Lykke³,Nygård Sune Boris³,Rømer Maria Unni⁴,Christensen Ib Jarle⁵,Høgdall Estrid²,Moreira José³,Nielsen Dorte L.¹,Brünner Nils³,Stenvang Jan³

Affiliation:

1. Department of Oncology; Herlev Hospital, University of Copenhagen; Herlev Denmark

2. Department of Pathology; Herlev Hospital, University of Copenhagen; Herlev Denmark

3. Department of Veterinary Disease Biology; Faculty of Health and Medical Sciences, University of Copenhagen; Denmark

4. Department of Clinical Physiology; Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen; Glostrup Denmark

5. The Finsen Laboratory; Rigshospitalet and Biotech Research and Innovation Centre (BRIC), University of Copenhagen; Denmark

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference26 articles.

1. Irinotecan in the treatment of colorectal cancer;Fuchs;Cancer Treat Rev,2006

2. A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer;Kumler;Breast Cancer Res Treat,2013

3. Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study;Awada;Lancet Oncol,2013

4. Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer;Horisberger;Anticancer Drugs,2009

5. Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy;Kostopoulos;BMC Cancer,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncoproteins E6 and E7 upregulate topoisomerase I to activate the cGAS-PD-L1 pathway in cervical cancer development;Frontiers in Pharmacology;2024-08-02

2. DNA damage repair factor TOP1 induces tumor-promoting inflammation and PD-L1 production via a cGAS-dependent manner during cervical cancer development;2023-09-06

3. Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer;Journal of Medicinal Chemistry;2021-11-30

4. Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial;Molecular Oncology;2021-09-12

5. Trastuzumab Modulates the Protein Cargo of Extracellular Vesicles Released by ERBB2+ Breast Cancer Cells;Membranes;2021-03-12